D-1454-2016 Class II Terminated

Recalled by Isomeric Pharmacy Solution, LLC — Salt Lake City, UT

FDA drug recall D-1454-2016 was initiated by Isomeric Pharmacy Solution, LLC on Aug 1, 2016 and is designated Class II. Reason for recall: Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethasone Sodium Phosphate 7 mg/mL INJ SUSP because of the potential of drug clumps in the vial of… The recall status is terminated (terminated Aug 1, 2017). Affected quantity: 2,331 vials.

Recall details

Product Type
Drugs
Report Date
Aug 10, 2016
Initiation Date
Aug 1, 2016
Termination Date
Aug 1, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,331 vials

Product description

Betamethasone Acetate / Betamethasone Sodium Phosphate Injectable Suspension, 7 mg/ mL,10 mL Multi-Dose vial for injection, Rx Only, Isomeric Pharmacy Solution, 2401 Foothill Dr., Salt Lake City, UT 84109

Reason for recall

Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethasone Sodium Phosphate 7 mg/mL INJ SUSP because of the potential of drug clumps in the vial of the sterile drug product and larger particle sizes.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot# 03037, Exp 8/17/16; 03042, 03043, Exp 8/31/16; 04043, Exp 9/29/16; 04047, 04048, Exp 10/1/16; 04052, 04053, Exp10/2/16; 05042, Exp 10/29/16; 05046, Exp 11/2/16; 05048, 05049, Exp 11/3/16; 05050 Exp 11/4/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1454-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1454-2016. Report a data issue: hello@regdatalab.com.